🟢 CalciMedica is trading 11% up in pre-market with no company-specific catalyst identified

CalciMedica is trading at $1.50, up 11.23%, with no company-specific announcement found to explain the November 5 pre-market move.

• The November 3 announcement concerned a November 10 investor conference, not a new clinical or financial development.
• Biotech was up 2.08% pre-market, offering a possible sector tailwind; this does not establish the cause of CalciMedica’s move.
• Trading volume data for this pre-market move was unavailable.